Optimizing Care in Lung Cancer: Current and Emerging Biomarkers for Immuno-Oncology

View an on-demand Webcast of a live CCO Webinar and then download the slides to gain expert perspectives from a medical oncologist and radiation oncologist on personalized IO therapy for patients with lung cancer, including discussion of the latest clinical data, when to use IO biomarker testing, and the intersection of radiation therapy and IO-based therapy in lung cancer.
Jamie E. Chaft, MD
Kristin Higgins, MD
Jamie E. Chaft, MD
Kristin Higgins, MD

Downloadable Slidesets

Download this slideset from Jamie E. Chaft, MD and Kristin Higgins, MD to review key data on the current use of IO biomarker testing, immunotherapy, and CRT for patients with lung cancer.

Jamie E. Chaft, MD Kristin Higgins, MD Released: October 23, 2020

Download this slideset from Jamie E. Chaft, MD and Kristin Higgins, MD to review key data and ongoing trials exploring the role of immunotherapy with CRT for patients with early stage NSCLC.

Jamie E. Chaft, MD Kristin Higgins, MD Released: October 23, 2020

Download this short summary slideset of key takeaways from a live CCO Webinar focused on key data for using biomarkers to select patients with lung cancer that may benefit from immune checkpoint inhibitors.

Jamie E. Chaft, MD Kristin Higgins, MD Released: October 29, 2020

On-Demand Webcast

Watch this on-demand Webcast capturing a live CCO Webinar with expert discussions on the evolving care of patients with lung cancer, with a focus on immunotherapy biomarkers and radiation therapy.

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue